Company news

Emergent BioSolutions Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Emergent BioSolutions Secures $51.9 Million Contract Modification Award for CNJ-016® [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) as part of U.S. Biodefense Preparedness Efforts

July 8, 2025

Emergent BioSolutions Expands NARCANDirect® to Offer KLOXXADO® (naloxone HCl) Nasal Spray 8 mg and Convenience Kits Amid Changes in Overdose Death Rate

July 2, 2025

Emergent BioSolutions Secures $62.4 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Bolster U.S. Biodefense Supply

June 23, 2025

Emergent BioSolutions Announces Addition to Russell 3000® Index

June 20, 2025

Emergent BioSolutions Supports Victoria's Voice Foundation’s National Naloxone Awareness Day Efforts on June 6 to Encourage Americans to Be Prepared for Opioid Emergencies

June 5, 2025

Emergent BioSolutions Reports First Quarter 2025 Financial Results

May 7, 2025

Emergent BioSolutions Reinforces Commitment to Opioid Emergency Preparedness Efforts in Canada Through Multi-Year Contract with Ontario Ministry of Health

May 1, 2025

Emergent BioSolutions to Report First Quarter 2025 Financial Results on May 7, 2025

April 22, 2025

Emergent BioSolutions Announces Stock Repurchase Program

March 31, 2025

Emergent BioSolutions New Hire Equity Grant Under NYSE Rule 303A.08

March 20, 2025

Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International

March 19, 2025

Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers with Five Critical Medical Countermeasure Products

March 18, 2025

Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs

March 13, 2025

Emergent BioSolutions and Rocketvax Announce Investment Agreement and Pursuit of a Strategic Relationship for Next-Generation Product Candidates

March 12, 2025

Emergent BioSolutions Announces Sale of Baltimore-Bayview Manufacturing Site to Syngene International

March 10, 2025

Emergent BioSolutions Reports Fourth Quarter and Full Year 2024 Financial Results

March 3, 2025

Emergent BioSolutions to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

February 18, 2025

← Newer news releases

Calls

The 5 newest of 26 calls. Every call is listed under its year.

Decks

The 5 newest of 46 decks. Every deck is listed under its year.